Insider · CIK 0001688195

Farzaneh-Far Ramin

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001688195

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-02	Ra Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−73.7K sh	—	—	0
2020-04-02	Ra Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−10.4K sh	—	—	0
2020-04-02	Ra Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−133K sh	—	—	0
2020-04-02	Ra Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−62.5K sh	—	—	0
2020-04-02	Ra Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−90K sh	—	—	0
2020-04-02	Ra Pharmaceuticals, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−14.5K sh	$48.00	−$696K	0
2020-04-02	Ra Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−11.1K sh	—	—	0
2020-03-16	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	73,654
2020-03-16	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2020-03-16	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2020-03-16	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$45.16	−$479K	7,132
2020-03-16	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	11,110
2020-02-18	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2020-02-18	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	82,860
2020-02-18	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	12,499
2020-02-18	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$46.61	−$494K	7,132
2020-02-18	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2020-01-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2020-01-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2020-01-15	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$46.95	−$497K	7,132
2020-01-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	13,888
2020-01-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	92,066
2019-12-16	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	101,272
2019-12-16	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	15,277
2019-12-16	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$47.23	−$500K	7,132
2019-12-16	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2019-12-16	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2019-11-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	16,666
2019-11-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2019-11-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2019-11-15	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$46.66	−$494K	7,132
2019-11-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	110,478
2019-10-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	119,684
2019-10-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2019-10-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2019-10-15	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$46.89	−$497K	7,132
2019-10-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	18,055
2019-09-16	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	128,890
2019-09-16	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2019-09-16	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2019-09-16	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$25.26	−$268K	7,132
2019-09-16	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	19,444
2019-08-23	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,389 sh	—	—	20,833
2019-08-23	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	138,096
2019-08-23	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2019-08-23	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2019-08-23	Ra Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−10.6K sh	$27.77	−$294K	7,132
2019-07-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,206 sh	$5.60	+$51.6K	17,727
2019-07-15	Ra Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,389 sh	$5.60	+$7,778.4	8,521
2019-07-15	Ra Pharmaceuticals, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,206 sh	—	—	147,302

Recent filings

Accepted (ET)
Apr 34
Farzaneh-Far Ramin0001104659-20-042769
SEC(opens sec.gov)
Mar 184
Farzaneh-Far Ramin0001104659-20-035491
SEC(opens sec.gov)
Feb 204
Farzaneh-Far Ramin0001104659-20-023526
SEC(opens sec.gov)
Jan 164
Farzaneh-Far Ramin0001104659-20-004828
SEC(opens sec.gov)

Companies

Ra Pharmaceuticals, Inc.Chief Medical Officer

Address

C/O RA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE

CAMBRIDGE, MA, 02140